The pharmacological blockade of DAGLβ by KT109 showed lower levels of 2-AG, arachidonic acid, and prostaglandins in Neuro2A cells, mouse peritoneal macrophages, mouse liver, and human prostate cancer cells (Hsu et al., 2012; Hsu et al., 2013). The gene discussed is DAGLB; the disease is prostate cancer.